BioSpace News Archive

Simcere Zaiming today announced two oral and six poster presentations will be presented on the Company’s preclinical programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting, taking place April 14-19, 2023, in Orlando, FL.

Jubilant Therapeutics Inc today announced publication of novel research demonstrating that a highly selective, non-competitive and orally administered inhibitor of Protein Arginine Deiminase 4 (PAD4), showed remarkable efficacy in two animal models of Rheumatoid Arthritis (RA).

PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTC PINK:ORHB), is pleased to announce the release of PURfiberXP™, a uniquely processed demineralized extracellular matrix (d-ECM) designed to support bone regeneration, cellular integration, and patient healing.

Sunstone Therapies, a leader in the development of clinical trials and the delivery of psychedelic-assisted therapy in the medical setting, today announces the publication of positive phase 2 data, assessing the effect of psilocybin therapy for patients with cancer and major depression disorder (MDD), in JAMA Oncology.

BioAegis Therapeutics, Inc. announces publication of two new research studies exploring gelsolin’s role in type 2 diabetes, an inflammation-related metabolic disease.

ClearPoint Neuro, Inc. announced successful registration of its Neuro Navigation portfolio with the Brazilian regulatory body, Agência Nacional de Vigilância Sanitária.

Nurix Therapeutics, Inc. (Nasdaq: NRIX) today reported financial results for the first quarter ended February 28, 2023 and provided a corporate update.

IGM Biosciences, Inc. announced the presentation of six posters at the upcoming American Association for Cancer Research Annual Meeting 2023, taking place in Orlando, Florida on April 14-19, 2023.

Sight Sciences, Inc., an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced it will host a Surgical Glaucoma Investor Symposium in San Diego, CA on Friday, May 5, 2023 at 6:00 pm PT.

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022.